Clinical Trials Browser

Esophageal Squamour Cell Cancer × camrelizumab × Clear all

NCT07191977 2025-09-25

Neoadjuvant Camrelizumab With Palbociclib for Resectable Esophageal Squamous Cell Carcinoma

Phase 2 Not yet recruiting

Gastrointestinal

Esophageal Squamour Cell Cancer